Loading…
Loading…
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion remains a Buy, with strong long-term growth potential driven by its shift toward higher-margin specialty ingredients and functional beverages. The proposed $5B Tate & Lyle acquisition offers transformative synergies, and rapid >15% Adj. EPS accretion potential, and geographic diversification, with $130M run-rate synergies identified by 2030. INGR's resilient business model, private-label exposure, and normalization at Argo support stable cash flows and a well-covered, growing dividend.
Ingredion's productivity initiatives, manufacturing improvements and cost discipline drive efficiency gains and support operational resilience despite persistent inflationary pressures.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
WESTCHESTER, Ill., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its third quarter 2026 financial results for the period ended September 30, 2026, before the market opens Thursday, November 5, 2026.
TRMB, INGR and DE offer exposure to precision agriculture, food innovation and smarter farming technologies shaping the AgTech landscape.
Ingredion's clean-label demand fuels T&HS volume growth and share gains, though rising tapioca costs may pressure near-term benefits.
Ingredion's T&HS growth is powered by clean-label, texture and nutrition demand, with 2026 sales and profit still expected to rise despite cost pressures.